Lupin Ltd. (LUPIN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 641789,
    "name": "Lupin",
    "stock_name": "Lupin",
    "full_name": "Lupin Ltd.",
    "name_url": "stocks-analysis/lupin",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "2,275.00",
    "chg": -85,
    "chgp": "-3.6%",
    "dir": -1,
    "prev_price": "2,360.00",
    "mcapval": "104,855.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 500257,
    "symbol": "LUPIN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE326A01037",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "02:43 AM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": "39.59 lacs",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/lupin-641789-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Lupin Ltd. Sees Sharp Surge in Derivatives Open Interest Amid Price Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-surge-in-derivatives-open-interest-amid-price-weakness-4145776",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_oi_spurts_by_underlying_4145776.png",
        "date": "2026-08-10 15:00:10",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 30.7% surge in open interest in its derivatives segment, even as the stock price declined by 3.8% on 10 Aug 2026. This divergence between rising open interest and falling price signals a complex market positioning that warrants close scrutiny from investors and traders alike."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amidst Weak Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amidst-weak-price-action-4145737",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_oi_spurts_by_underlying_4145737.png",
        "date": "2026-08-10 14:00:09",
        "description": "Lupin Ltd., a mid-cap pharmaceutical heavyweight, has witnessed a significant 30.26% surge in open interest (OI) in its derivatives segment, even as the stock price declined by 3.43% on 10 Aug 2026. This divergence between rising derivatives activity and falling spot prices signals evolving market positioning and potential directional bets among traders, warranting a closer examination of volume patterns, investor sentiment, and technical indicators."
      },
      {
        "title": "Lupin Ltd. Sees High-Value Trading Amidst Consecutive Declines and Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-high-value-trading-amidst-consecutive-declines-and-institutional-interest-4145739",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_most_active_equities_by_value_4145739.png",
        "date": "2026-08-10 14:00:09",
        "description": "Lupin Ltd., a prominent mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed significant trading activity on 10 Aug 2026, with over 24 lakh shares exchanging hands and a total traded value exceeding ₹55,160 lakhs. Despite this high-value turnover, the stock has experienced a notable decline over the past four sessions, underperforming its sector and broader market indices."
      },
      {
        "title": "Lupin Ltd. Hits Intraday Low Amid Price Pressure on 10 Aug 2026",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-hits-intraday-low-amid-price-pressure-on-10-aug-2026-4145674",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_priceRelatedfactors_4145674.png",
        "date": "2026-08-10 13:01:38",
        "description": "Lupin Ltd. experienced a notable decline today, touching an intraday low of Rs 2,236, reflecting a 5.25% drop as the stock faced significant price pressure and underperformed its sector peers in the Pharmaceuticals & Biotechnology industry."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amidst Weak Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amidst-weak-price-action-4145670",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_oi_spurts_by_underlying_4145670.png",
        "date": "2026-08-10 13:00:07",
        "description": "Lupin Ltd., a mid-cap pharmaceutical and biotechnology company, has witnessed a significant surge in open interest (OI) in its derivatives segment, rising by 24.29% to 46,619 contracts from 37,509. This spike comes despite the stock’s recent underperformance, including a 5.07% decline on 10 Aug 2026 and a four-day consecutive fall totalling a 7.01% loss. The divergence between derivatives activity and spot price movement signals evolving market positioning and potential directional bets among traders."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Surge in Derivatives Open Interest Amid Price Weakness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-surge-in-derivatives-open-interest-amid-price-weakness-4145625",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_oi_spurts_by_underlying_4145625.png",
        "date": "2026-08-10 12:00:09",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 16.46% surge in open interest in its derivatives segment, even as the stock price declined by over 4% on 10 Aug 2026. This divergence between rising open interest and falling price signals evolving market positioning and potential directional bets among traders, warranting a closer examination of volume patterns, investor sentiment, and technical indicators."
      },
      {
        "title": "Lupin Ltd. Sees Sharp Open Interest Surge Amidst Weak Price Action",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-sees-sharp-open-interest-surge-amidst-weak-price-action-4145557",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_oi_spurts_by_underlying_4145557.png",
        "date": "2026-08-10 11:00:09",
        "description": "Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.55% surge in open interest in its derivatives segment, even as the stock price declined by 3.53% on 10 Aug 2026. This divergence between rising open interest and falling prices signals evolving market positioning and potential directional bets among traders, warranting a closer examination of volume patterns, investor sentiment, and technical indicators."
      },
      {
        "title": "Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4144644",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_technicaldot_4144644.png",
        "date": "2026-08-10 08:02:39",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent dip of 1.32% in its share price to ₹2,360.00, the stock continues to demonstrate resilience amid mixed signals from key technical indicators such as MACD, RSI, and moving averages."
      },
      {
        "title": "Lupin Ltd. Valuation Shifts Signal Enhanced Price Attractiveness Amid Sector Dynamics",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/lupin-ltd-valuation-shifts-signal-enhanced-price-attractiveness-amid-sector-dynamics-4144535",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/LupinLtd_valuationdot_4144535.png",
        "date": "2026-08-10 08:01:09",
        "description": "Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. This change reflects improved price metrics relative to its historical averages and peer group, signalling a compelling opportunity for investors amid a mixed sector backdrop."
      }
    ],
    "total": 744,
    "sid": "641789",
    "stock_news_url": "https://www.marketsmojo.com/news/lupin-641789"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "08-Aug-2026",
      "details": "Copies of Newspaper publication in respect of Unaudited Financial Results of the Company for the quarter ended June 30 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "07-Aug-2026",
      "details": "Link of Audio recording of the Earnings Call-Q1 FY27.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
      "datetime": "07-Aug-2026",
      "details": "Investor Presentation (Revised) - Q1 FY27 Results",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has declared <strong>900%</strong> dividend, ex-date: 17 Jul 26",
          "dt": "2026-07-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>2:10</strong> stock split, ex-date: 27 Aug 10",
          "dt": "2010-08-27",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Lupin Ltd. has announced <strong>1:1</strong> bonus issue, ex-date: 11 Aug 06",
          "dt": "2006-08-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Lupin Ltd. Sees Sharp Surge in Derivatives Open Interest Amid Price Weakness

2026-08-10 15:00:10

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a significant 30.7% surge in open interest in its derivatives segment, even as the stock price declined by 3.8% on 10 Aug 2026. This divergence between rising open interest and falling price signals a complex market positioning that warrants close scrutiny from investors and traders alike.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Amidst Weak Price Action

2026-08-10 14:00:09

Lupin Ltd., a mid-cap pharmaceutical heavyweight, has witnessed a significant 30.26% surge in open interest (OI) in its derivatives segment, even as the stock price declined by 3.43% on 10 Aug 2026. This divergence between rising derivatives activity and falling spot prices signals evolving market positioning and potential directional bets among traders, warranting a closer examination of volume patterns, investor sentiment, and technical indicators.

Read full news article

Lupin Ltd. Sees High-Value Trading Amidst Consecutive Declines and Institutional Interest

2026-08-10 14:00:09

Lupin Ltd., a prominent mid-cap player in the Pharmaceuticals & Biotechnology sector, witnessed significant trading activity on 10 Aug 2026, with over 24 lakh shares exchanging hands and a total traded value exceeding ₹55,160 lakhs. Despite this high-value turnover, the stock has experienced a notable decline over the past four sessions, underperforming its sector and broader market indices.

Read full news article

Lupin Ltd. Hits Intraday Low Amid Price Pressure on 10 Aug 2026

2026-08-10 13:01:38

Lupin Ltd. experienced a notable decline today, touching an intraday low of Rs 2,236, reflecting a 5.25% drop as the stock faced significant price pressure and underperformed its sector peers in the Pharmaceuticals & Biotechnology industry.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Amidst Weak Price Action

2026-08-10 13:00:07

Lupin Ltd., a mid-cap pharmaceutical and biotechnology company, has witnessed a significant surge in open interest (OI) in its derivatives segment, rising by 24.29% to 46,619 contracts from 37,509. This spike comes despite the stock’s recent underperformance, including a 5.07% decline on 10 Aug 2026 and a four-day consecutive fall totalling a 7.01% loss. The divergence between derivatives activity and spot price movement signals evolving market positioning and potential directional bets among traders.

Read full news article

Lupin Ltd. Sees Sharp Surge in Derivatives Open Interest Amid Price Weakness

2026-08-10 12:00:09

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 16.46% surge in open interest in its derivatives segment, even as the stock price declined by over 4% on 10 Aug 2026. This divergence between rising open interest and falling price signals evolving market positioning and potential directional bets among traders, warranting a closer examination of volume patterns, investor sentiment, and technical indicators.

Read full news article

Lupin Ltd. Sees Sharp Open Interest Surge Amidst Weak Price Action

2026-08-10 11:00:09

Lupin Ltd., a mid-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.55% surge in open interest in its derivatives segment, even as the stock price declined by 3.53% on 10 Aug 2026. This divergence between rising open interest and falling prices signals evolving market positioning and potential directional bets among traders, warranting a closer examination of volume patterns, investor sentiment, and technical indicators.

Read full news article

Lupin Ltd. Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-10 08:02:39

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, transitioning from a bullish to a mildly bullish trend. Despite a recent dip of 1.32% in its share price to ₹2,360.00, the stock continues to demonstrate resilience amid mixed signals from key technical indicators such as MACD, RSI, and moving averages.

Read full news article

Lupin Ltd. Valuation Shifts Signal Enhanced Price Attractiveness Amid Sector Dynamics

2026-08-10 08:01:09

Lupin Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. This change reflects improved price metrics relative to its historical averages and peer group, signalling a compelling opportunity for investors amid a mixed sector backdrop.

Read full news article

View All News